socio-economic benefits

R&D

It has been estimated that 12% of the UK population suffer from irritable bowel syndrome (IBS), an umbrella term that describes a bro

News

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.